Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction

Fig. 2

LDL level and compliance rate on admission and short-term follow-up among different lipid-lowering strategies in AMI patients. A. LDL level and compliance rate among different lipid-lowering strategies on admission and at the 1- and 3-month follow-ups. Each point represents one AMI patient’s lipid data. B LDL alterations among different lipid-lowering strategies on admission and at the 1st and 3rd month follow-ups. Data are shown as the mean ± SEM LDL Target Level = 1.4 mmol/L

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X